High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award: 868. (October 2016)